FindTrial
Sign In

Effect of hypertension on perioperative bleeding in joint replacement

Effect of hypertension on perioperative bleeding in joint replacement

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025516
Enrollment
Unknown
Registered
2019-08-31
Start date
2019-08-28
Completion date
Unknown
Last updated
2019-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty

Interventions

1:Hypertension group
2:Normal blood pressure group

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Primary joint replacement; 2. Hypertension group HP (> 140/90); 3. Non-hypertensive group HP < 140/90.

Exclusion criteria

Exclusion criteria: 1. Revision after arthroplasty; 2. With blood system related diseases; with coagulation dysfunction and other medical diseases; 3. Preoperative use of anticoagulant drugs such as aspirin; 4. 24 hours of fluid replacement more than 2,000 ml.

Design outcomes

Primary

MeasureTime frame
blood loss;Blood transfusion volume;Hemoglobin;Perioperative blood pressure;—

Countries

China

Contacts

Public ContactChen Xiang-yang

Affiliated Hospital of Xuzhou Medical University

1173503735@qq.com+86 15905201635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026